Safety and Efficacy of Conbercept in Neovascular Age-Related Macular Degeneration: Results from a 12-Month Randomized Phase 2 Study: AURORA Study
作者： Xiaoxin Li , Gezhi Xu , Yusheng Wang , Xun Xu , Xiaoling Liu
DOI: 10.1016/J.OPHTHA.2014.03.026
关键词:
摘要: Purpose To assess the safety and efficacy of multiple injections of 0.5 and 2.0 mg conbercept using variable dosing regimens in patients with neovascular age-related macular …
sci-hub.se 参考文章(15)
Chun Yang, Dechao Yu, Hong Li, Mi Yan, Ming Zhang, Junjun Zhang, Recombinant anti-vascular endothelial growth factor fusion protein efficiently suppresses choridal neovasularization in monkeys. Molecular Vision. ,vol. 14, pp. 37- 49 ,(2008)
Quan Dong Nguyen, Peter A Campochiaro, Syed Mahmood Shah, David J Browning, Henry L Hudson, Peter L Sonkin, Seenu M Hariprasad, Peter K Kaiser, Jason Slakter, Julia A Haller, Diana V Do, William Mieler, Karen Chu, Avner Ingerman, Robert Vitti, Alyson J Berliner, Jesse Cedarbaum, and the CLEAR-IT 1 Investigators, None, Evaluation of Very High- and Very Low-Dose Intravitreal Aflibercept in Patients with Neovascular Age-Related Macular Degeneration Journal of Ocular Pharmacology and Therapeutics. ,vol. 28, pp. 581- 588 ,(2012) , 10.1089/JOP.2011.0261
Daniel F Martin, Maureen G Maguire, Stuart L Fine, Gui-shuang Ying, Glenn J Jaffe, Juan E Grunwald, Cynthia Toth, Maryann Redford, Frederick L Ferris 3rd, Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, None, Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology. ,vol. 119, pp. 1388- 1398 ,(2012) , 10.1016/J.OPHTHA.2012.03.053
Ming Zhang, Junjun Zhang, Mi Yan, Delun Luo, Wenjin Zhu, Peter K Kaiser, De-Chao Yu, KH902 Phase 1 Study Group, None, A phase 1 study of KH902, a vascular endothelial growth factor receptor decoy, for exudative age-related macular degeneration. Ophthalmology. ,vol. 118, pp. 672- 678 ,(2011) , 10.1016/J.OPHTHA.2010.08.008
Feucht, Pegaptanib sodium treatment in neovascular age-related macular degeneration: clinical experience in Germany. Clinical Ophthalmology. ,vol. 2, pp. 253- 259 ,(2008) , 10.2147/OPTH.S2842
J. Holash, S. Davis, N. Papadopoulos, S. D. Croll, L. Ho, M. Russell, P. Boland, R. Leidich, D. Hylton, E. Burova, E. Ioffe, T. Huang, C. Radziejewski, K. Bailey, J. P. Fandl, T. Daly, S. J. Wiegand, G. D. Yancopoulos, J. S. Rudge, VEGF-Trap: A VEGF blocker with potent antitumor effects Proceedings of the National Academy of Sciences of the United States of America. ,vol. 99, pp. 11393- 11398 ,(2002) , 10.1073/PNAS.172398299
Ming Zhang, Dechao Yu, Chun Yang, Qingjie Xia, Wang Li, Bin Liu, Hong Li, The pharmacology study of a new recombinant human VEGF receptor-fc fusion protein on experimental choroidal neovascularization. Pharmaceutical Research. ,vol. 26, pp. 204- 210 ,(2009) , 10.1007/S11095-008-9718-9
Jeffrey S. Heier, Ranibizumab Combined With Verteporfin Photodynamic Therapy in Neovascular Age-Related Macular Degeneration Archives of Ophthalmology. ,vol. 124, pp. 1532- 1542 ,(2006) , 10.1001/ARCHOPHT.124.11.1532
Germaine Fuh, Bing Li, Craig Crowley, Brian Cunningham, James A. Wells, Requirements for Binding and Signaling of the Kinase Domain Receptor for Vascular Endothelial Growth Factor Journal of Biological Chemistry. ,vol. 273, pp. 11197- 11204 ,(1998) , 10.1074/JBC.273.18.11197
Akeo Shinkai, Mikito Ito, Hideharu Anazawa, Sachiko Yamaguchi, Kenya Shitara, Masabumi Shibuya, Mapping of the Sites Involved in Ligand Association and Dissociation at the Extracellular Domain of the Kinase Insert Domain-containing Receptor for Vascular Endothelial Growth Factor Journal of Biological Chemistry. ,vol. 273, pp. 31283- 31288 ,(1998) , 10.1074/JBC.273.47.31283